Why Celator Pharmaceuticals Is Up 1,610% In 2016

Image source: Getty Images.What: Shares of Celator Pharmaceuticals (NASDAQ: CPXX), a clinical-stage oncology-focused biopharmaceutical company, have rocketed 1,610% higher year to date, according to data from S&P Global Market Intelligence. Stellar data from a candidate aimed at an underserved population, and subsequent acquisition by Jazz Pharmaceuticals (NASDAQ: JAZZ) launched this biotech into orbit.Continue reading

BING NEWS:
  • Nanomedicine Strategies for Hematological Malignancies: What Is Next?
    MDS Liposomal carrier CPX-351 (Celator, Vancouver, Canada) Biocompatible, amphiphilic; biodegradability; targeting potential; low toxicity Liposomal carrier Nanobins Biocompatible, amphiphilic ...
    04/19/2024 - 12:59 pm | View Link
  • Religions of Rome
    Wayne G. Sayles, The Celator "Religions of Rome is a major work from a major press that will likely be widely read and cited for years to come. Often, it is worthy of such a status." The Journal of ...
    12/23/2022 - 12:23 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News